Evidence map›Paper›PMID 42465237›Full record

ArticlebioRxiv : the preprint server for biology2026

Benchmarking AlphaFold and related deep learning approaches for modeling antibody and TCR antigen recognition.

Rui Yin, Shayana Saravanakumar, Shu Yuan Shi, Minjae Park, Valerie Lin, Jessica Lee, Melyssa Cheung, Nathaniel Felbinger, Sivan Kaufman, Maya Eisenberg and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rui YinDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Shayana SaravanakumarDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Shu Yuan ShiDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Minjae ParkDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Valerie LinDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Jessica LeeDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Melyssa CheungDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Nathaniel FelbingerDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Sivan KaufmanDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Maya EisenbergDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.
Brian G PierceDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.

Funding

High resolution modeling and design of immune recognitionR35GM144083 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI Brian G. Pierce · 2022 to 2026
$1.6M
NIGMS NIH HHS R35 GM144083
6 · The paper itself

Abstract

Determining the structural basis of antigen recognition by antibodies and T cell receptors (TCRs) provides critical insights into effective immune targeting and can inform design of biotherapeutics and vaccines. Accurate computational modeling of antibodies and TCRs in complex with their targets poses a major challenge for predictive methods, including AlphaFold, which is generally accurate for modeling protein complexes but has shown limited success for immune recognition. In this study we assessed the performance of AlphaFold2, AlphaFold3, increased sampling protocols, and related deep learning methods for modeling antibody-protein, antibody-peptide, and TCR-peptide-major histocompatibility complex (pMHC) recognition. We show that increased sampling and AlphaFold3 generally improve performance relative to default sampling and AlphaFold2, however predictive accuracy and improvement levels varied considerably among interface classes, with antibody-peptide complexes representing a challenge despite their small antigen size. Comparing per-case success across methods showed some complementarity, indicating opportunities for increased success through model pooling approaches, for instance increasing antibody-peptide near-native success from 41% to 59%. Analysis of AlphaFold confidence scores and modeling of a noncanonical complex provided further insights into predictive performance. These results highlight considerations for predictive antibody and TCR complex modeling efforts, while revealing key distinctions among protocols, scoring, and immune complex classes.

Identifiers

PMID42465237
PMCPMC13370930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.